Evidence map›Paper›PMID 34917084›Full record

ReviewFrontiers in immunology2021

Infectious Keratitis: An Update on Role of Epigenetics.

Sudhir Verma, Aastha Singh, Akhil Varshney, R Arun Chandru, Manisha Acharya, Jyoti Rajput, Virender Singh Sangwan, Amit K Tiwari, Tuhin Bhowmick, Anil Tiwari

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Role of epigenetics in corneal health and disease.Progress in retinal and eye research · 2025
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Sudhir VermaDepartment of Zoology, Deen Dayal Upadhyaya College (University of Delhi), New Delhi, India.
Aastha SinghDepartment of Cornea and Uveitis, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
Akhil VarshneyDepartment of Cornea and Uveitis, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
R Arun ChandruPandorum Technologies Ltd., Bangalore Bioinnovation Centre, Bangalore, India.
Manisha AcharyaDepartment of Cornea and Uveitis, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
Jyoti RajputPandorum Technologies Ltd., Bangalore Bioinnovation Centre, Bangalore, India.
Virender Singh SangwanDepartment of Cornea and Uveitis, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
Amit K TiwariDepartment of Pharmacology and Experimental Therapeutics, The University of Toledo, Toledo, OH, United States.
Tuhin BhowmickPandorum Technologies Ltd., Bangalore Bioinnovation Centre, Bangalore, India.
Anil TiwariDepartment of Cornea and Uveitis, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
Dr. Shroff’s Charity Eye Hospital · INUniversity of Delhi · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epigenetic mechanisms modulate gene expression and function without altering the base sequence of DNA. These reversible, heritable, and environment-influenced mechanisms generate various cell types during development and orchestrate the cellular responses to external stimuli by regulating the expression of genome. Also, the epigenetic modifications influence common pathological and physiological responses including inflammation, ischemia, neoplasia, aging and neurodegeneration etc. In recent past, the field of epigenetics has gained momentum and become an increasingly important area of biomedical research As far as eye is concerned, epigenetic mechanisms may play an important role in many complex diseases such as corneal dystrophy, cataract, glaucoma, diabetic retinopathy, ocular neoplasia, uveitis, and age-related macular degeneration. Focusing on the epigenetic mechanisms in ocular diseases may provide new understanding and insights into the pathogenesis of complex eye diseases and thus can aid in the development of novel treatments for these diseases. In the present review, we summarize the clinical perspective of infectious keratitis, role of epigenetics in infectious keratitis, therapeutic potential of epigenetic modifiers and the future perspective.

Indexed as

Epigenesis, GeneticAnimalsEye InfectionsHumansKeratitisepigeneticshistone modificationsinfectiouskeratitismethylation

Identifiers

PMID34917084
PMCPMC8669721
OpenAlexW3215358025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.